(Q33340029)

25 July 2017

1 reference

title

A synopsis of the clinical uses of argatroban (English)

1 reference

25 July 2017

M Moledina

1

1 reference

25 July 2017

M Chakir

series ordinal

2

1 reference

25 July 2017

P J Gandhi

series ordinal

3

1 reference

25 July 2017

publication date

1 October 2001

1 reference

Journal of Thrombosis and Thrombolysis

25 July 2017

published in

1 reference

25 July 2017

volume

12

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

141-149

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1012919404290

25 July 2017

exact match

0 references

cites work

Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor

1 reference

12 December 2020

Heparin-induced thrombocytopenia: towards consensus.

1 reference

12 December 2020

Successful Coronary Interventions Performed with Argatroban Anticoagulation in Patients with Heparin-Induced Thrombocytopenia and Thrombosis Syndrome

1 reference

12 December 2020

Effect of argatroban on thrombus formation during acute coronary occlusion after balloon angioplasty.

1 reference

12 December 2020

Choice of anticoagulant in a congenital antithrombin III (AT III)-deficient patient with chronic renal failure undergoing regular haemodialysis

1 reference

12 December 2020

Importance of antithrombin therapy during coronary angioplasty

1 reference

12 December 2020

Temporal aspects of heparin-induced thrombocytopenia

1 reference

12 December 2020

Effects of an antithrombotic agent (MD-805) on progressing cerebral thrombosis.

1 reference

12 December 2020

Argatroban: a synthetic thrombin inhibitor of low relative molecular mass

1 reference

12 December 2020

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin

1 reference

12 December 2020

Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia

1 reference

12 December 2020

Effective anticoagulation by argatroban during coronary stent implantation in a patient with heparin-induced thrombocytopenia

1 reference

12 December 2020

Combined administration of aspirin and a specific thrombin inhibitor in man

1 reference

12 December 2020

Cellular effects of thrombin: pharmacology of the receptor(s) in various cell types and possible development of receptor antagonists

1 reference

12 December 2020

Inhibitory effect of argatroban on thrombin-antithrombin III complex after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Inhibition of factor Xa-induced platelet aggregation by a selective thrombin inhibitor, argatroban

1 reference

12 December 2020

Novel antithrombotic approaches to coronary artery disease

1 reference

12 December 2020

Antithrombin III deficiency in ischaemic stroke

1 reference

12 December 2020

Clinical Application of the Synthetic Thrombin Inhibitor, Argatroban (MD-805)

1 reference

12 December 2020

Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation

1 reference

12 December 2020

Antigen Generation in Heparin-Associated Thrombocytopenia: The Nonimmunologic Type and the Immunologic Type Are Closely Linked in Their Pathogenesis

1 reference

12 December 2020

Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis

1 reference

12 December 2020

Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban.

1 reference

12 December 2020

Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects

1 reference

12 December 2020

Current concepts: the use of heparin

1 reference

12 December 2020

Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters

1 reference

12 December 2020

Heparin-induced thrombocytopenia in coronary bypass surgery

1 reference

12 December 2020

Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT.

1 reference

12 December 2020

Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin.

1 reference

12 December 2020

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction

1 reference

12 December 2020

[Left heart bypass with the bio-medicus centrifugal pump by the use of an antithrombin agent, argatroban]

1 reference

12 December 2020

The human pharmacology of thrombin inhibition.

1 reference

12 December 2020

The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report

1 reference

12 December 2020

Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.

1 reference

12 December 2020

Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome

1 reference

12 December 2020

Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III.

1 reference

12 December 2020

A 14-year study of heparin-induced thrombocytopenia

1 reference

12 December 2020

Argatroban During Percutaneous Transluminal Coronary Angioplasty: Results of a Dose-Verification Study.

1 reference

12 December 2020

Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.

1 reference

12 December 2020

A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1012919404290

1 reference

Dimensions Publication ID

25 July 2017

1003089125

0 references

1 reference